Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). CBP did disclose a “Seized Asset Management and Enforcement Procedures Handbook,” dated January 2002, that it said explains the CBP policies related to seizing and destroying controlled substances like ayahuasca. Drug Enforcement Administration (DEA). Customs Border Patrol (“CBP”) and U.S.

DEA 97

DEA Blood Pressure Safety Policy 97

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 105

Law Therapy Clinical Trials Research and Development 105

PrestoDoctor

JULY 16, 2019

The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. According to plaintiff José Belén, “the DEA was told to act with ‘great dispatch’ and with ‘all deliberate speed”. Americans for Safe Access (ASA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. According to plaintiff José Belén, “the DEA was told to act with ‘great dispatch’ and with ‘all deliberate speed”. Americans for Safe Access (ASA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2, 2002 , 116 Stat. 2, 2002 , 116 Stat. 2, 2002 , 116 Stat. 2(a), Oct. 21, 1998 , 112 Stat.

Banking 45

Banking Law Marijuana State Laws 45